Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.298 EUR | -12.87% | -4.49% | -27.32% |
May. 15 | Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M | MT |
Apr. 30 | Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals and Medical Products
100.0
%
| 26 | 100.0 % | 32 | 100.0 % | +25.30% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
68.9
%
| 17 | 66.6 % | 22 | 68.9 % | +29.70% |
Germany
19.4
%
| 5 | 18.5 % | 6 | 19.4 % | +31.37% |
Spain
5.4
%
| - | - | 2 | 5.4 % | - |
Other European Countries
3.7
%
| - | - | 1 | 3.7 % | - |
United Kingdom
2.2
%
| - | - | 1 | 2.2 % | - |
Other Regions
0.3
%
| 0 | 1.3 % | 0 | 0.3 % | -69.01% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 55 | 22-09-11 | |
Anke zur Muehlen
IRO | Public Communications Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 21-12-13 | |
Heikki Lanckriet
BRD | Director/Board Member | 46 | 21-12-13 |
Helge Lubenow
CHM | Chairman | 56 | 21-12-13 |
Director/Board Member | 65 | 22-08-22 | |
Jörgen Tielmann
BRD | Director/Board Member | - | 21-12-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,038,431 | 984,371 ( 32.40 %) | 0 | 32.40 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
BIOFRONTERA INC. 7.86% | 400,000 | 7.86% | 676,000 $ |
Company contact information
Sector
Sales per region
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- B8FK Stock
- B8F Stock
- Company Biofrontera